<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Walkley House Medical Centre</h1>
        This is some intro text.

        <h2>Prescribing where Walkley House Medical Centre is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=1001040A0&amp;denomIds=10.1.4&amp;selectedTab=summary">Benzbromarone</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Gout and cytotoxic induced hyperiuicaemia</td>
      <td>641</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>21.43</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=1001040A0AAAAAA&amp;denomIds=10.1.4&amp;selectedTab=summary" target="_blank">Benzbromarone 100mg tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=1309000P0&amp;denomIds=13.9&amp;selectedTab=summary">Cetrimide</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Shampoos and some other scalp preparations</td>
      <td>110</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>14.12</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=1309000P0BEAAAG&amp;denomIds=13.9&amp;selectedTab=summary" target="_blank">Ceanel Concentrate shampoo : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=1001010AD&amp;denomIds=10.1.1&amp;selectedTab=summary">Ibuprofen lysine</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>9</td>
      <td>Non-steroidal anti-inflammatory drugs</td>
      <td>820</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>10.43</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAKTUlEQVR4nO2df9BVRRnHPwsKaqAgKWipxzDMklRyNPxVSgK6aBOYmjnmSCNpmmQpR6ux/DEuYxiNTEKaY5Y/Mn8EciihsrTUtPyBZUr+WNTQNEVRKQXd/nj2Za4v72v3vveccy/3PJ+ZnRfe99599jn3fs/u2X32WRNCQFGUatCv1Q1QFKU8VPCKUiFU8IpSIVTwilIhVPCKUiFU8IpSIVTwilIhVPCKUiFU8IpSIVTwilIhVPDKu2OMxl53EBu1ugEASZq9B9gb2A/YF1gNLAQy7+xzrWybonQSplWbZ5I0Gwh8C5gADAfuBv4Yy2DgMMACryDiv8E7+3BLGltljAmEYFrdDCUfWiL4JM02B24G/gbMBp70zvbYkCTNRgGTgFOAo7yz95bWUEUF32GULvgkzbYBMuBq7+ysBt63F3ANsL939tmi2qd0QwXfUZQ6aZek2c7A74BZjYgdwDt7D/Bt4KYkzTbJv3WK0vmU1sMnabY3cC0wzTu7pIl6LgLeC5zQ22OAkiPaw3cUpfTwSZqNRsR+RDNij6TACGB60w1TlIpR1pD+MGCOd/a+Zivyzr4FfA74YpJm45tumaJUiLLW4fcBzs+rMu/sy0maTQZ+maTZLcAqZPmu6+f93tlledlTlE6h8B4+SbN+wB7A/XnW6519FDgEWbdfDgTg/cBY5EYwOU97itIJFD5pl6TZLsBl3tn9CjX0TpvbAwuAq4Hv6uReE+ikXUdRxjP8PkgvXBre2aeAA4CDgHlJmm1cpn1FaVfKEvydJdh5B97ZVchk4RpgUZJmQ8pug6K0G2UJ/q4S7KyHd3YtEpKbAbcnaTa0Fe1QlHah0Gf4JM2GAXd5Z0cVZqT+tpyOTOgdqc/0DaDP8B1F0T38WFownO+F2cguvKmtboiitIqiBd+S5/ee8M6+DXwBODuuHChK5aiM4AG8s/8CTgKu0Q04ShUpTPBxKWwU0FZJK7yztwK/BVyr26IoZVNkaO3uwINxKN1unA3cmaSZ9c5msG6C8dPAEUACTPDOPt26JipK/hQ5pG+r4Xwt3tk3gGOAOUmanZqk2RLgz8BHgQuBc4EFSZoNbmEzFSV3ihT8vrSp4GFdLP5pwPZIbr2R3tnp3tk7vLPXAdcD1yVp1haJPhUlDwr5MidpZpAstCcUUX9eeGcXIDH3PeGAHwEXA18prVGKUiCFBN7EzSu/8M6Oyb3yEknSbADwK+Bm7+wlPfx9ILCJd/aVHG1+BJgFPA6c1/I03Rp401EUJfijgf28s6fkXnnJxHDcPwBnemezJM12AibGsgewFvgm8NNmIviSNNs01nMk8HVgRySrz4+RHICrmnKkr6jgO4qinuHb+vm9EbyzK4HDkQm+fyCpukYgQ/4E8fU44IYkzbbqi40kzQ5G8gUMAHb3zs73zs4GdgP6A0vj5OKAZv1Rqk1RPfxfgMne2eW5V94ikjTbFljrnX2+h7/1QwJ6vgZMj3MD/6++jZCbxTRgJ+BE7+wD72L7HGREMc47+2qfHWkU7eE7itwFn6TZIOSAiaRqm1TioRlXAY8iz/5PA88AK7yzb8ZrMwEZMYxDevWfIzn636qj/hQ4EJjknV1TjBfdUMF3FEUI/iDgJO/sZ3OteAMh9tzHA7siKbe2A7YFukTza2A+sNg7+3qDdRvgEmQT0PGl3FBV8B1FEctybRtwUwZxD/7l3X8fQ43frqcnf5e6Q5JmpyGjgvOQSb7udoYAXwWGAPP0PD6lliJ6+L8Cx/b2PKo0T5zRX4I8Clwaf7cZcCpwMnAlsAKZV3gJ+AEwv0+PAdrDdxRFCP507+zFuVaqrEeSZlsCtyNhwFshS3k3Ac47+0J8jUEmBk8GPo6MPGbF0OL6yEnwsS2fQJYx72pmpKP0nZYdF600T5JmOyCTg3cgQTq9bvZJ0mwEcBYiuuO8s0vrMmJMSGYsnARMAcYDjyApw7J6c//Hg0AdssT4GrJn4TdIlONi7+xrdbVFaRoVfMVI0mwcMA+YC3yvp542riaMB6b4mZOOSWYs/BlwI3Jz+RBgkSO8BwOLgN8Dfwcej3MYXfXsDFwAjERuNrfGeYhBwMHIasWngIcQ8d/inf1nIY63MXHeZYh31hdtSwVfQWL04BzgfUgWoKeRNf4JiNBHIjkDbvQzJ83vbUgfj/4+FHlc2CW+byUi/jeAPYHvANf2tk06SbP+8f2HI1mGVyPiz4B/x5eZHkrt7/sDWyKHjNaWZ5DTih9qx23aSZoNRyZYjwFeR9o7F1hQ1LKrCr7CJGl2FDATWa15BFgcy9J1AmnwGT5GG+6CCG6hd/bNBts0ChH+IcgIItQUuv2/q7wFvIjcILrKS0h48ieBnYF7EfEvjfUORW4SQ4EtkGPKnovl2fhzDTI/snVNGRzruNM7u6IR32p83B44A7nJzUUmVVcB+wNfQla6foJs3lqe5/KrCr7ixOHkml5jAjpglj6mM9sLEf+HkfMHVyI3hZXx/5sjIdO1ZQDwfCwvxJ+rkeQuY4FBwJ+QZehneecIpB9yI92iWxkOjAa+D1zunV3dQ3u3RmI5jkVuMi8gx6kt985+uamLEULItQAn5l1nK+2oTxuGHfWpvlLE5pkTC6izlXbKtKU+bRi2NlifyjofXlGUNkAFrygVogjB/7CAOltpp0xb6tOGYWuD9Uln6RWlQuiQXlEqREPbY40xByBBAc+HEK4wxkxGoqseQ5JefB5Z15wDnB/f9g0k6+tQ4KoQwmM521qA5IEbEUKYboy5Hrg9hDAnZztXIkESi0IIVxljzgE2BWaGEFbmbOs64Ggk+GQKcEWOPj0JuBDCRGPMMGTTzX9CCOcW4FOtrTFIJN9A5GDPddcyZzu7IzPbi4GF1HwPQwh1bdhpwNYoJNJwIvJ55enTy/FvrwJX0+Tn1EWjPfzYEIJDoo8APhhCuAg5UsoiF3cgkottCZLsYTckgOF8JIIqV1shhCfi67oCR14ENjXG1BssUq9PbyNi3CwK5Rlk99mBBfj0XAhhNnBPCOG1PH0KITyARJyBBKJcDqwowqdaWyGE+0IIFwIbU3Mt87YDvImIZDPW/x7m7dMy4FIkyWnePt2GbDgaRj6fE9C44Ls/8Nc7AVAbGpm7LWPMZ4DbAEIIJwHLkIwzudkJIayKdQ9EIqz6QiM+jUFSYBXmU0404tM04Praa2mMqfd0n3o/p4dDCDOAD9RZb59tRSzSqxfh05nAZXXWVReNCv5uY8wM4CVjzMeAx4wxZyA53BYhw/f/Ag8iu6DGxX+vQbKz3JK3LWPMaCQR5K7GmMHGmLOQnVhP5GxnO2NMCuwAPIVsPJlKvNHkaSu+9lAgM8YMytMnY8yOwL7GmKOQnmoqsE0I4cW8faq1ZYyZGH3Ys9u1rHdrbL12Rsfr1Z/1v4e5+hRfu0cI4b4CfJqG3LTGks/nBOgsvaJUCp2lV5QKoYJXlAqhgleUCqGCV5QKoYJXlAqhgleUCqGCV5QKoYJXlAqhgleUCqGCV5QKoYJXlArxP4tdZ2wiGX05AAAAAElFTkSuQmCC"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=1001010ADAAACAC&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Ibuprofen lysine 400mg tablets : 9</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0406000AF&amp;denomIds=4.6&amp;selectedTab=summary">Granisetron</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Drugs used in nausea and vertigo</td>
      <td>627</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>9.56</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0406000AFAAAAAA&amp;denomIds=4.6&amp;selectedTab=summary" target="_blank">Granisetron 3.1mg/24hours transdermal patches : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0410020D0&amp;denomIds=4.10.2&amp;selectedTab=summary">Nicotine bitartrate</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Nicotine dependence</td>
      <td>36</td>
      <td>0.17</td>
      <td>0.0</td>
      <td>0.03</td>
      <td>6.26</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAEEUlEQVR4nO3dPYgcZRzH8e+IL2gQBBGJEFwUUyiKmsaoiCj4wlmI2FsIQURMp1vauWolNsFC1EasFHWjqGgKxQO5FAYR9MAVsQn41gUE/xY7RW4zOXdvnmdnhuf7geNeuP3fj2V/N88+N7dTRQSSynBB1wEkrY+Flwpi4aWCWHipIBZeKoiFlwpi4aWCWHipIBZeKoiFlwpi4dehqjx/Wb1g4aWCWHipIBZeKkirwo/G0ytTBZGUX9sj/H1JUkhai7aFfyBJCklr0bbw94/G0ypJEknZtS38aeBgiiCS8mtb+M9wWS8NRtvCf4qFlwajbeE3gUOj8fTiFGEk5dWq8LPJxj/At8AdaeJIyinFmXYu66WBSFX4BxPMkZRZisJvA/tH4+mlCWZJyqh14WeTjQC+A25uH0dSTqn+W24LOJRolqRMLLxUkFSFPwncnmiWpExSFf5X4OrReHpJonmSMkhS+Hrj7hRu3Em9lvIlrrZwWS/1WsrCn8SNO6nXUh/hLbzUYykL/wtwjf85J/VXssLXG3ffAzelmikprdSvS++yXuoxCy8VJEfh/dOc1FOpC/8zcGA0nl6UeK6kBJIWvt64+wG4MeVcSWnkuJiky3qpp3IU/jhwdDSeXp5htqQWkhd+Ntk4AbwDvDsaTy9MPV/S3uW6PvzLwG/Aq157TuqPLIWvN++eZn7duaM5foak1VURkW34aDy9gvn15/YDfwN/NbydAQL4t36f4+Nlvne3t1ZmLz0yHT3/0UaKWbW+zUk5q29zUs5KMmc22fhir7dtVfiqqo5ExOt7HrBmQ8sLw8s8tLwwvMxt8rZd0h9peft1G1peGF7moeWF4WXec95cm3aSesjCSwVpW/jBPO+pDS0vDC/z0PLC8DLvOW/WXXpJ/eKSXirISqe+VlV1D3AncDoi3qiq6jHgemA7It7LEbCthsyPAg9FxFMdR2vUkPcJ5i8b9nFEfNltumYNmR8GbgNORcSH3aY712Le+mvHgDcjYrPTcOfRcB+/wPw8luMR8eOyc1Y9wh+OiAlwVf35DRHxCvMz6vpqR+aIeB+YdZpod4t53wKOAdd1mmp3i4+LTeAA85Oq+mhH3vrAdaLTRP9v8T7+Hdi36pBVC7/4hH8IGwBDyHi2HXmrqtoHPAm83U2cpezIHBF/As/Q319Si4+JW4C7gbs6yLKsxfv4NeBF4PFVhqy0aVcvKw4DfzC/8MS1zJf0P9VHzt5pyHwZ8BwwiYivu8zWpCHvs8A28HlEfNNltvNpyHwr88fFZkR80GW2Jot5I2Krqqp7gTM9X9KffR8fZP5U76uI+GTpOe7SS+Vwl14qiIWXCmLhpYJYeKkgFl4qiIWXCmLhpYJYeKkgFl4qiIWXCmLhpYL8B3U5U8zqu02HAAAAAElFTkSuQmCC"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0410020D0AAABAB&amp;denomIds=4.10.2&amp;selectedTab=summary" target="_blank">Nicotine bitartrate 1mg lozenges sugar free : 6</a></div></td></tr></tbody></table>

        <h2>Prescribing where Walkley House Medical Centre is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0302000C0&amp;denomIds=3.2&amp;selectedTab=summary">Beclometasone dipropionate</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>527</td>
      <td>Corticosteroids (respiratory)</td>
      <td>1723</td>
      <td>0.31</td>
      <td>0.57</td>
      <td>0.12</td>
      <td>-2.19</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAIdElEQVR4nO3df6xXdR3H8efncjPERGtkJeQ+y1/N/JEyLPzdStMOU3O0layWUmRWmjK6HyQKVPTg1Ag2ZuGcqVu6YirxwfqjZZkbQUopm0riDoIOEUEtAyX59Mf7Q9zuvSj38j3nc77f835sZ9/vvWy831/4vr7nnM/5nM/XhBBQSjVDV+oGlFLV0cAr1SAaeKUaRAOvVINo4JVqEA28Ug2igVeqQTTwSjWIBl6pBtHAK9Ug9Q28MTrnV6kW607dgBqYdf5QYBxwAnAEcBAwkt3/ZyFuvZ/3/RngbWATsAF4DlgFrC7ybHvJL0HVkKntzTPGBEIwqduoknX+IODiuI0CHgX+DjwDvAq8DuwATNzo9bzvz7uedwOHAGOAI4ETgeOAtYAHlhR59nSZr0vVhwa+BqzzBwPfBy4BFgP3AKuKPCvlP8c6b4DjgS8AXwK2AYuA+4o821ZGTVUPGviErPPvAS4HrgZ+Acwr8mxLgj7GApcBnwMWAD8r8uyNqvtQ5dPAJ2Kd/ywwD1gBXFPk2UuJW8I6PxqYBlwI3IIE/620XalW0sBXzDpvgZuRc+orijxbkbaj/mLwfwScBVwL/LLIs51Jm1ItoYGviHV+JNADfAWYDdxd9xBZ548GrkeuElwD/LascQVVDQ18yazz3cA3kLDfA9xU5Nk/03Y1ONb5cUAODANckWfLE7ekhkgDX5I4Ep4hQVkJzCzybEParoYuvp6zgRuRa/rXFnn2WNqu1GBp4EtgnT8GGZDrBqYWebYqcUstY53vAi4AfghsBK7TPX770MC3ULyePgu5vt0DPNCp57y9jmBmAq8hwX8kbVfq3WjgW8A6PwyYDEwHbgduacrU1Rj8c5BR/beA64A/dOoHXbvTwO8j6/zpwE+Bp4Cedj5P3xcx+J9BjnD+DVxV5NlTSZtS/Wjgh8g6fxhwE3LJ6soizx5N3FItxOB/ERmsXAbMLvJsa9qu1C4a+EGyzu8P/AD4OnKN+s4iz95O2lQNWeeHI1OGpyDhX6T/Tulp4PdS3HNNBG4AliCXpV5L21X9xVl7OXAsciT0p8QtNZoGfi9Y509C5pZvR85N9XbSQbLOjwfmI7flTivybH3ilhpJA/8OrPNjgDnAWOQy2zIdfR66eA3/EuQa/h3AzXo7brU08AOwzr8PCfhXkcPR24s8+0+KXjpRnK/wY2BCfLy37vcVdAoNfC/xevqlyI0i9wI3Fnn2epU9NIl1/ihgLnAoMiPxz4lb6nga+Mg6/3nkMtuTwIwiz9ZVVbvprPNnIrcMP4/MZXg2cUsdq/GBt84fi7zZRiB7mZVl11T9xfP7i5GJO0uA61Os/tPpGht46/yHkcUdzkAO4e/XAbn04jyHq4BvAT8BFuqqO63TuMBb50cgE0K+ib6hait+IM8GzgQc8KB+IO+7xgQ+HjJOQg4ZH0QPGdtCPOWaD7wBfK/IsyJtR+2t4wMfR94nAjOQ9d1dkWdr9/XvVdWJsxwnIXfi3QbcWuTZjrRdtaeODbx1/kDga8B3gNXIHv2JVrWnqmed/wCy4s544HK9jDd4HRX4uCcYjwQ9Q77UYWGRZ2tK6FAlYp0/BVgI/BW5jPdK4pbaRtsHPob8k8g3qExEruXeDSwu8uxf5TapUolf4nElcgQ3C7hLB/XeXVsGPoZ8LBLwi5C11X6NhPyF6ppUqcV1CeYDBwPf1kU33lnbBD6GfBy7Q74B+BVy/fzFNE2qurDOX4BMoHoYmKOj+QOrdeBtz9L9kHPy85FVVNaxO+QbU7an6sc6vx9yN9404BFgQZFnj6ftql5qF/h4S+q5xdwJi2zP0heBx5CvNb6/yLNNabtT7cA6/15kTOe7wE7kizoXF3m2OWljNZA08PET+Xjg08Cn4rYDeKiYO2Gq7Vk6vMizN5M1qNpeXLxkEnIauAZ4KG5rmjjIV0ng4/pmRwAfj9vR8XE08ATwl7it+N+ncA0WwFCdI860PBk4DzgXee89zu733somLFk25MDHf8D3A6OAD8bHXc9HAx+N20eQ9crXAk/32p4B1u9x4QMNvCpRvEnnJOSo8mRkQLgLeZ/+A3g2Pj4PbAJe7oTZfYMKvHV+JTASOBAIwFZgc9xe7vX8BWA9MpK+cUirlWrgVcWs8wcAhyNHo0fGbQxwCLIj6wZeBbYga+/33t5Exgt2Itno/TjQ7/r+Wd8g7vHnIs/mDPlFhhBqtQFTtGb719Oa9azXNeRPivJM0ZodUU9r1rBeHQOvlCqJBl6pBqlj4H+uNTuintasYb3azbRTSpWnjnt4pVRJulM3AGCMOQM4BdgUQrjDGHMecCLwZAjhN2XXi7+7DbgzhLC81fUGqmmMmYVc010WQihlgY4Bap6O3Iy0PITQ8i91HKDehcAxwP4hhJmtrreHmpOReSKEEOZVVPNS5PbcdSGExSXVPAu4LITw5fjzZOBDwB9DCHv9VeV12cOPDyHkyOQGgOXILL3tVdQzxlyE3FZZpr6v8RXggIprng9sQyZ7lF4vhPAAMnPtvpLq9asJDEOCUOaNVn1rHhZCuBWZsluKEMLDwN96/WpUCOEG4LTB/D11Cfz/DSSEELYidzp9rIp6yA08pwGnllSvX80QwgJkfbaJVdUERsa651RUD+C4EMLqkuoNVLMrhDAdmTFXVc3fG2OuAKqciz+kwbdaHNIDy40xPcAWY8xYZMmqw5E9fen1Qgiz4iFTWUcU/WoCRwGfAMpciLFvzd8ZY65G1hWoot5zyDTUMvWtOcIYMxV4qcKaXcBwZPnzUhhjTgBONcbMAO4CNhtjpgODOjXTUXqlGqQuh/RKqQpo4JVqEA28Ug2igVeqQTTwSjWIBl6pBtHAK9UgGnilGkQDr1SDaOCVahANvFIN8l9GG3qoq9wyDwAAAABJRU5ErkJggg=="></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0302000C0BPAABE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 50micrograms/dose inhaler : 47</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0302000C0BPABBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 100micrograms/dose inhaler : 322</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0302000C0BQAABX&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair 100micrograms/dose / 6micrograms/dose inhaler : 86</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0302000C0BQABBZ&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair 200micrograms/dose / 6micrograms/dose inhaler : 31</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0302000C0BJABBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 100 inhaler : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0302000C0BPADBW&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 250micrograms/dose inhaler : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0302000C0AABXBX&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 100microg/Formoterol 6microg/dose inh CFCfree : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0302000C0BJAEBG&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 50micrograms/dose Easi-Breathe inhaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0302000C0BJAFBH&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 100micrograms/dose Easi-Breathe inhaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0302000C0BPACBV&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 200micrograms/dose inhaler : 24</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0302000C0BRAABY&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair NEXThaler 100microg/dose / 6microg/dose dry pdr inh : 5</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0302000C0BRABCA&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair NEXThaler 200microg/dose / 6microg/dose dry pdr inh : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0309010C0&amp;denomIds=3.9.1&amp;selectedTab=summary">Codeine phosphate</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Cough suppressants</td>
      <td>9</td>
      <td>0.00</td>
      <td>0.76</td>
      <td>0.35</td>
      <td>-2.17</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0601011A0&amp;denomIds=6.1.1&amp;selectedTab=summary">Insulin aspart</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>90</td>
      <td>Short-acting insulins</td>
      <td>166</td>
      <td>0.54</td>
      <td>0.79</td>
      <td>0.12</td>
      <td>-2.12</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0601011A0BBABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">NovoRapid Penfill 100units/ml inj 3ml cartridges : 61</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0601011A0BBAAAA&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">NovoRapid 100units/ml solution for injection 10ml vials : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0601011A0BBADAC&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">NovoRapid FlexPen 100units/ml inj 3ml pre-filled pens : 17</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0601011A0BCABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Fiasp Penfill 100units/ml inj 3ml cartridges : 10</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=1305030C0&amp;denomIds=13.5.3&amp;selectedTab=summary">Tacrolimus</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Drugs affecting the immune response</td>
      <td>10</td>
      <td>0.40</td>
      <td>0.81</td>
      <td>0.21</td>
      <td>-1.95</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=1305030C0AAAAAA&amp;denomIds=13.5.3&amp;selectedTab=summary" target="_blank">Tacrolimus 0.1% ointment : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=1305030C0AAACAC&amp;denomIds=13.5.3&amp;selectedTab=summary" target="_blank">Tacrolimus 0.03% ointment : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C88005&amp;numIds=0205020M0&amp;denomIds=2.5.2&amp;selectedTab=summary">Moxonidine</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Centrally-acting antihypertensive drugs</td>
      <td>13</td>
      <td>0.00</td>
      <td>0.64</td>
      <td>0.34</td>
      <td>-1.91</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr></tbody></table>
        <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
        <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
    </div>

</body>

</html>